91 related articles for article (PubMed ID: 38665920)
1. A novel approach to pH-Responsive targeted cancer Therapy: Inhibition of FaDu cancer cell proliferation with a pH low insertion Peptide-Conjugated DGAT1 inhibitor.
Deskeuvre M; Lan J; Messens J; Riant O; Feron O; Frédérick R
Int J Pharm; 2024 May; 657():124132. PubMed ID: 38641019
[TBL] [Abstract][Full Text] [Related]
2. Generation of cellular immune responses to antigenic tumor peptides.
Pietersz GA; Apostolopoulos V; McKenzie IF
Cell Mol Life Sci; 2000 Feb; 57(2):290-310. PubMed ID: 10766024
[TBL] [Abstract][Full Text] [Related]
3. Targeted acidosis mediated delivery of antigenic MHC-binding peptides.
Kelly JJ; Ankrom ET; Newkirk SE; Thévenin D; Pires MM
Front Immunol; 2024; 15():1337973. PubMed ID: 38665920
[TBL] [Abstract][Full Text] [Related]
4. Targeted Acidosis Mediated Delivery of Antigenic MHC-Binding Peptides.
Kelly JJ; Ankrom E; Thévenin D; Pires MM
bioRxiv; 2023 Oct; ():. PubMed ID: 37904977
[TBL] [Abstract][Full Text] [Related]
5. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
7. Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy.
Ma W; Smith T; Bogin V; Zhang Y; Ozkan C; Ozkan M; Hayden M; Schroter S; Carrier E; Messmer D; Kumar V; Minev B
J Transl Med; 2011 Mar; 9():34. PubMed ID: 21450109
[TBL] [Abstract][Full Text] [Related]
8. Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28.
Han JF; Zhao TT; Liu HL; Lin ZH; Wang HM; Ruan ZH; Zou LY; Wu YZ
Cancer Immunol Immunother; 2006 Dec; 55(12):1575-83. PubMed ID: 16534571
[TBL] [Abstract][Full Text] [Related]
9. Measurement of Accumulation of Antibiotics to Staphylococcus aureus in Phagosomes of Live Macrophages.
Kelly JJ; Dalesandro BE; Liu Z; Chordia MD; Ongwae GM; Pires MM
Angew Chem Int Ed Engl; 2024 Jan; 63(3):e202313870. PubMed ID: 38051128
[TBL] [Abstract][Full Text] [Related]
10. Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR.
Zhang AQ; Hostetler A; Chen LE; Mukkamala V; Abraham W; Padilla LT; Wolff AN; Maiorino L; Backlund CM; Aung A; Melo M; Li N; Wu S; Irvine DJ
Nat Biomed Eng; 2023 Sep; 7(9):1113-1128. PubMed ID: 37291434
[TBL] [Abstract][Full Text] [Related]
11. Neoantigens: promising targets for cancer therapy.
Xie N; Shen G; Gao W; Huang Z; Huang C; Fu L
Signal Transduct Target Ther; 2023 Jan; 8(1):9. PubMed ID: 36604431
[TBL] [Abstract][Full Text] [Related]
12. Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments.
Niemi JVL; Sokolov AV; Schiöth HB
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291947
[TBL] [Abstract][Full Text] [Related]
13. A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy.
Zhang Z; Rohweder PJ; Ongpipattanakul C; Basu K; Bohn MF; Dugan EJ; Steri V; Hann B; Shokat KM; Craik CS
Cancer Cell; 2022 Sep; 40(9):1060-1069.e7. PubMed ID: 36099883
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity.
Backlund CM; Holden RL; Moynihan KD; Garafola D; Farquhar C; Mehta NK; Maiorino L; Pham S; Iorgulescu JB; Reardon DA; Wu CJ; Pentelute BL; Irvine DJ
Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2204078119. PubMed ID: 35914154
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
